Oxford Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-36,308
Closed -$1.3M 802
2019
Q4
$1.3M Sell
36,308
-8,836
-20% -$305K 0.04% 694
2019
Q3
$1.54M Sell
45,144
-9,574
-17% -$306K 0.04% 697
2019
Q2
$1.53M Buy
54,718
+37,141
+211% +$1.03M 0.03% 768
2019
Q1
$545K Buy
+17,577
New +$469K 0.01% 1184
2018
Q3
Sell
-53,691
Closed -$1.82M 1831
2018
Q2
$1.82M Buy
53,691
+1,885
+4% +$67.1K 0.03% 718
2018
Q1
$1.88M Buy
+51,806
New +$1.79M 0.04% 613
2017
Q4
Sell
-16,650
Closed -$627K 1760
2017
Q3
$627K Sell
16,650
-936
-5% -$31.9K 0.01% 1127
2017
Q2
$549K Buy
17,586
+3,020
+21% +$87.2K 0.01% 1081
2017
Q1
$359K Buy
+14,566
New +$342K 0.01% 1151

Other funds holding LMAT

Oxford Asset Management's LMAT Position: Q1 2020 in Review

Oxford Asset Management sold out of LeMaitre Vascular (LMAT) in Q1 2020, closing a stake of 36,308 shares — an estimated $1.3M sold.

Oxford Asset Management first reported a position in LMAT in Q1 2017 and held it in 9 quarters. The position peaked at $1.88M in Q1 2018. 144 funds tracked by Wall St. Rank hold LMAT as of Q1 2020.

  • Oxford Asset Management reported no remaining LeMaitre Vascular position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 36,308 LeMaitre Vascular shares in Q1 2020, an estimated $1.3M.
  • Oxford Asset Management first reported a position in LeMaitre Vascular in Q1 2017 and held it in 9 quarters.
  • Oxford Asset Management's LeMaitre Vascular position peaked at $1.88M in Q1 2018.
  • 144 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.